Prevention of relapse is a major goal of maintenance treatment in patients with psychotic disorders. We performed a long-term comparison of a newer, atypical antipsychotic drug, risperidone, and an ...

There is a continuing debate in schizophrenia research about the effectiveness of currently available antipsychotic drugs. This concerns, amongst other issues, the treatment of cognitive deficits; one ...

Risperidone is a second-generation antipsychotic that lacks acute motor side effects at low doses (<6 mg/day), but above this level is associated with parkinsonism and akathesia. The literature ...

The antipsychotic cariprazine (Reagila) is not only more effective than risperidone in treating patients with schizophrenia and persistent negative symptoms (PNS), it is also safe and effective for ...

The drug: Although the exact mechanism of action of risperidone is unknown, the drug blocks receptors in the dopaminergic, adrenergic and histaminergic neurotransmitter systems as well as those in the ...